Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Sees Large Increase in Short Interest

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX - Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 290,200 shares, a growth of 323.6% from the March 31st total of 68,500 shares. Currently, 0.8% of the shares of the stock are sold short. Based on an average daily volume of 1,820,000 shares, the days-to-cover ratio is presently 0.2 days.

Biodexa Pharmaceuticals Trading Up 1.1 %

Biodexa Pharmaceuticals stock traded up $0.02 during mid-day trading on Friday, hitting $1.43. 12,908 shares of the company traded hands, compared to its average volume of 583,519. Biodexa Pharmaceuticals has a one year low of $1.14 and a one year high of $74.00. The stock has a fifty day moving average price of $1.92 and a 200-day moving average price of $3.79.

Biodexa Pharmaceuticals Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.